Document is current
Any future updates will be listed below
-
Authors
Zuroff, Leah https://orcid.org/0000-0002-8527-6174
Farkhondeh, Vista https://orcid.org/0000-0002-1327-6722
Bove, Riley https://orcid.org/0000-0002-2034-8800
Green, Ari J. https://orcid.org/0000-0001-9275-3066
- License Information
-
More Information
Article History
Accepted: 3 July 2025
First Online: 16 September 2025
Declarations
:
: Not applicable.
: Leah Zuroff has received speaking fees from EMD Serono. Vista Farkhondeh has no relevant disclosures. Riley Bove has received research support from Biogen, Eli Lilly, Novartis, and Roche Genentech. She has received personal fees for advisory boards and consulting from Alexion, Amgen, Cadenza, EMD Serono, Sanofi, and TG Therapeutics. Ari Green reports grants from the NINDS, NMSS, All May See, Westridge Foundation, and other financial relationships for activities as expert witness, associate editor, advisory board or steering committee participation, and endpoint adjudication from JAMA Neurology, Roche, Pipeline Pharmaceuticals, and Cognito Therapeutics.
: Not applicable.
: Not applicable.
: Not applicable.
: No original data were presented in the manuscript.
: Not applicable.
: Leah Zuroff and Ari Green conceived of the idea for the article. Leah Zuroff, Vista Farkhondeh, and Riley Bove performed relevant literature search and drafted the manuscript and figures. Riley Bove and Ari Green critically revised the work.
